JACKSONVILLE, Fla., June 24, 2021 / PRNewswire / – Marco Ophthalmic, a leading ophthalmic technology company, has signed a distribution agreement with Olleyes, Inc., which offers intuitive and easy-to-use virtual reality ophthalmic products. With immediate effect, Marco will add the VisleyALL S VRP® (Virtual Reality Platform) Olleyes to its existing portfolio of ophthalmic medical devices.
VisuALL is the latest virtual reality visual field analyzer available on the market that can be used in clinical practice to detect glaucoma and evaluate other eye diseases.
“VisuALL is a multi-test virtual reality platform that increases physicians’ efficiency. The platform brings several advantages over current technologies. Our partnership with Marco will help more clinicians and patients benefit from VisuALL throughout the weather. the United States, “he said Alberto Gonzalez-Garcia MD, CEO of Olleyes.
According to scientific studies and surveys, glaucoma is the most common cause of irreversible blindness. Based on prevalence studies, it is estimated that 79.6 million individuals had glaucoma in 2020 and this number is likely to increase to 111.8 million individuals in 2040. In many cases, glaucoma can be asymptomatic. Unfortunately, many people are unaware of the existence of glaucoma and up to half of people with glaucoma are unaware that they are affected.
In many cases, blindness can be prevented with proper control and treatment, and VisuALL can help with the early detection of these diseases.
“Marco is one of the largest and most respected suppliers of ophthalmic medical equipment and devices in the country, and Olleyes is very excited to participate in this distribution partnership,” he said. Armond Dantino, Vice President of Business Development at Olleyes. “By expanding our distribution network everywhere the United States, el VisuALL S VRP it has the potential to reach an additional 200 million people. The collaboration with Marco’s team helps Olleyes realize our company’s vision of providing a convenient, accurate, reliable and cost-effective solution for managing visual diagnoses. ”
Jocelyn Hamilton, head of sales and vice president / CEO of Marco Ophthalmic, commented: “We are rapidly running our innovation pipeline and building a complete set of products in the ophthalmic technology space. Our focus is on meeting the needs of the market in this constant change the environment has been very strategic and we are excited to collaborate with Olleyes to promote and distribute VisuALL to visual care professionals.
For more information on VisuALL, go to marco.com/product/visual-vrp-lays.
As for the advancement of eye care
Advancing Eyecare ™ is an association of market leaders in eye care instrumentation established to provide the best products and service solutions to the ophthalmic equipment industry. Currently comprised of Marco Ophthalmic, Lombart Instrument, Enhanced Medical Services (EMS), Ophthalmic Instruments, Inc., S4OPTIK and INNOVA Medical, the combined scope of the organization has the broadest product portfolio, the most expert people and the service more reliable. in industry. Visit www.advancingeyecare.com for more information.
About Marco Ophthalmic
As a leader in vision diagnosis®, Marco continues to revolutionize the ophthalmic industry with a complete set of automated refraction and diagnostic devices, as well as a wide range of high-end classic examination rail equipment. Marco is a member of the Advancing Eyecare Alliance. Visit www.marco.com for more information.
Olleyes, Inc. equips visual care professionals with the instrument, tools, and education needed to effectively diagnose and treat patients with glaucoma and other eye diseases. Olleyes was created by a visionary neuroophthalmologist and a group of professionals who saw the need to make eye care accessible and personalized. The company manufactures intuitive, easy-to-use products equipped with artificial intelligence, virtual reality (VR), eye tracking, and proprietary algorithms to make eye assessment faster and more reliable. Visit www.olleyes.com for additional information.
Contact with the media:
Chris Tofalli Public Relations, LLC
SOURCE Marco Ophthalmic